State Street’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.9K | Hold |
151,377
| – | – | ﹤0.01% | 4064 |
|
|
2025
Q1 | $52.5K | Hold |
151,377
| – | – | ﹤0.01% | 4089 |
|
|
2024
Q4 | $89.5K | Buy |
151,377
+11,771
| +8% | +$6.96K | ﹤0.01% | 4009 |
|
|
2024
Q3 | $246K | Hold |
139,606
| – | – | ﹤0.01% | 3781 |
|
|
2024
Q2 | $191K | Sell |
139,606
-651,672
| -82% | -$893K | ﹤0.01% | 3836 |
|
|
2024
Q1 | $2.72M | Buy |
791,278
+66,909
| +9% | +$230K | ﹤0.01% | 3174 |
|
|
2023
Q4 | $1.78M | Hold |
724,369
| – | – | ﹤0.01% | 3349 |
|
|
2023
Q3 | $1.23M | Buy |
724,369
+12,100
| +2% | +$20.6K | ﹤0.01% | 3474 |
|
|
2023
Q2 | $2.14M | Buy |
712,269
+579,063
| +435% | +$1.74M | ﹤0.01% | 3385 |
|
|
2023
Q1 | $357K | Buy |
133,206
+13,600
| +11% | +$36.4K | ﹤0.01% | 3861 |
|
|
2022
Q4 | $987K | Buy |
119,606
+40,000
| +50% | +$330K | ﹤0.01% | 3560 |
|
|
2022
Q3 | $613K | Buy |
79,606
+23,600
| +42% | +$182K | ﹤0.01% | 3699 |
|
|
2022
Q2 | $160K | Sell |
56,006
-228,955
| -80% | -$654K | ﹤0.01% | 4305 |
|
|
2022
Q1 | $1.43M | Sell |
284,961
-841,960
| -75% | -$4.21M | ﹤0.01% | 3689 |
|
|
2021
Q4 | $22.1M | Buy |
1,126,921
+183,152
| +19% | +$3.6M | ﹤0.01% | 2408 |
|
|
2021
Q3 | $27.8M | Buy |
943,769
+296,300
| +46% | +$8.72M | ﹤0.01% | 2239 |
|
|
2021
Q2 | $27.4M | Buy |
647,469
+477,387
| +281% | +$20.2M | ﹤0.01% | 2300 |
|
|
2021
Q1 | $8.65M | Buy |
+170,082
| New | +$8.65M | ﹤0.01% | 2802 |
|